Gossamer Bio GOSS
NASDAQ GOSS
$0.15 -0.01 (-3.49%)
As of: Aug 21, 2026 · 11:54 AM EDT

Gossamer Bio (GOSS) Asset Utilization Ratio (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly Asset Utilization Ratio of 0.37 for Q1 2026, up 9.25% year-over-year from 0.34 in Q1 2025, and up 44.99% quarter-over-quarter from 0.25 in Q4 2025.

Gossamer Bio (GOSS) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Gossamer Bio's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.37 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 9.25% year-over-year to 0.37; the TTM figure through Mar 2026 stood at 0.37 (up 9.25% YoY), while the FY2025 annual figure was 0.2, down 31.25% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.37, up from 0.25 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.37 in Q1 2026, with the low at 0.06 in Q2 2025.
  • The 3-year median for Asset Utilization Ratio is 0.28 (2024), against an average of 0.25.
  • The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio tumbled 79.44% in 2025, then increased 9.25% in 2026.
  • Gossamer Bio's Asset Utilization Ratio stood at 0.27 in 2024, then dropped by 6.58% to 0.25 in 2025, then soared by 44.99% to 0.37 in 2026.
  • Business Quant data shows GOSS's Asset Utilization Ratio at 0.37 in Q1 2026, 0.25 in Q4 2025, and 0.09 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 139.90 Bn 132.05 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn 0.38
3 Argenx Se 65.73 Bn 60.55 Bn 1.37 Bn -
4 Moderna 58.33 Bn 53.19 Bn 52.00 Mn 0.20
5 BeOne Medicines 42.16 Bn 37.07 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 31.72 Bn 28.42 Bn 992.69 Mn 0.90
7 BioNTech SE 28.27 Bn 9.88 Bn 668.28 Mn 0.13
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn 0.54
9 Royalty Pharma 27.25 Bn 26.41 Bn - 0.13
10 Gossamer Bio 48.77 Mn -8.26 Mn - 0.52

Historic Data

Download Data
DateValue
Jun 30, 2026 0.52
Mar 31, 2026 0.37
Dec 31, 2025 0.25
Sep 30, 2025 0.09
Jun 30, 2025 0.06
Mar 31, 2025 0.34
Dec 31, 2024 0.27
Sep 30, 2024 0.29
Jun 30, 2024 0.30